Skip to main content

Playback every public session from the inaugural 2024 Global Investors' Symposium right here on our website.

Name
Panel: FDA: Recalibrating the Benefit-Risk Equation

Panel: FDA: Recalibrating the Benefit-Risk Equation

Robert Conley, Geoff Duyk, Patrick Frey, Hugh Hempel, Howard McLeod, Kate Rawson

Published